Akero Therapeutics
AKRO
AKRO
190 hedge funds and large institutions have $2.06B invested in Akero Therapeutics in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 65 increasing their positions, 50 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.13% more ownership
Funds ownership: 105.14% → 106.28% (+1.1%)
5% more call options, than puts
Call options by funds: $17.2M | Put options by funds: $16.3M
1% less capital invested
Capital invested by funds: $2.09B → $2.06B (-$30.5M)
Holders
190
Holding in Top 10
9
Calls
$17.2M
Puts
$16.3M
Top Buyers
| 1 | +$33.5M | |
| 2 | +$26.2M | |
| 3 | +$22.3M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$18.1M |
| 5 |
SG Americas Securities
New York
|
+$16.2M |
Top Sellers
| 1 | -$43.5M | |
| 2 | -$29M | |
| 3 | -$17.5M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$14.7M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$14.5M |